antihemophilic factor viii (Recombinant) (Adynovate) Report issue

Active Ingredient History

  • Now
Factor VIII is a medication used to treat and prevent bleeding in people with hemophilia A and other causes of low factor VIII. Certain preparations may also be used in those with von Willebrand's disease. It is given by slow injection into a vein.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
advate | adynovate | antihemophilic factor, human (monoclonal) | antihemophilic factor, human recombinant | antihemophilic factor recombinant | antihemophilic factor (recombinant) | antihemophilic factor,recombinant | antihemophilic factor, recombinant | antihemophilic factor (recombinant), pegylated | antihemophilic factor (recombinant), plasma/albumin-free method | antihemophilic factor (recombinant), rahf | bax 855 | bay 14-2222 | bay-14-2222 | bay14-2222 | bay 81-8973 | bay94-9027 | bebulin | factor viii (rdna) | factor viii recombin | factor viii (recombinant) | factor viii, recombinant | greengene f | human coagulation factor viii / human von willebrand factor | human factor viii recombinant | human factor viii (recombinant) | iblias | monoclate | monoclate-p | monoelate-p | nuwiq | octocog alfa | pegylated recombinant factor viii | rahf | recombinant antihemophilic factor | recombinant antihemophilic factor viii | recombinant coagulation factor | recombinate | recombinate | sct800


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue